Shanghai Titan Scientific Co. Ltd. A (688133) - Total Assets
Based on the latest financial reports, Shanghai Titan Scientific Co. Ltd. A (688133) holds total assets worth CN¥4.86 Billion CNY (≈ $710.45 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Shanghai Titan Scientific Co. Ltd. A debt service capacity to assess how comfortably operating cash covers total debt obligations.
Shanghai Titan Scientific Co. Ltd. A - Total Assets Trend (2013–2025)
This chart illustrates how Shanghai Titan Scientific Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See 688133 book value for net asset value and shareholders' equity analysis.
Shanghai Titan Scientific Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shanghai Titan Scientific Co. Ltd. A's total assets of CN¥4.86 Billion consist of 61.1% current assets and 38.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 18.1% |
| Accounts Receivable | CN¥667.42 Million | 13.7% |
| Inventory | CN¥1.06 Billion | 21.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥198.54 Million | 4.1% |
| Goodwill | CN¥123.07 Million | 2.5% |
Asset Composition Trend (2013–2025)
This chart illustrates how Shanghai Titan Scientific Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shanghai Titan Scientific Co. Ltd. A stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Titan Scientific Co. Ltd. A's current assets represent 61.1% of total assets in 2025, a decrease from 78.4% in 2013.
- Cash Position: Cash and equivalents constituted 18.1% of total assets in 2025, up from 7.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 21.7% of total assets.
Shanghai Titan Scientific Co. Ltd. A Competitors by Total Assets
Key competitors of Shanghai Titan Scientific Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Inner Mongolia Junzheng Energy & Chemical Group Co Ltd
SHG:601216
|
China | CN¥42.81 Billion |
|
Jinan Shengquan Group Share Holding Co Ltd
SHG:605589
|
China | CN¥18.10 Billion |
|
Shenzhen Senior Technology Material Co Ltd
SHE:300568
|
China | CN¥25.67 Billion |
|
CNNC Hua Yuan Titanium Dioxide Co Ltd
SHE:002145
|
China | CN¥19.62 Billion |
|
Shandong Shida Shenghua Chem
SHG:603026
|
China | CN¥12.53 Billion |
|
Snowsky Salt Industry Group Co Ltd
SHG:600929
|
China | CN¥12.69 Billion |
|
Anhui Hwasu Co.Ltd.
SHG:600935
|
China | CN¥9.87 Billion |
|
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
|
China | CN¥5.30 Billion |
Shanghai Titan Scientific Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.82 | 2.16 | 3.71 |
| Quick Ratio | 1.16 | 1.39 | 2.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.31 Billion | CN¥1.66 Billion | CN¥1.30 Billion |
Shanghai Titan Scientific Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shanghai Titan Scientific Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.27 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | CN¥4.87 Billion |
| Market Capitalization | $526.72 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Titan Scientific Co. Ltd. A's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai Titan Scientific Co. Ltd. A's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai Titan Scientific Co. Ltd. A (2013–2025)
The table below shows the annual total assets of Shanghai Titan Scientific Co. Ltd. A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.87 Billion ≈ $712.19 Million |
+0.38% |
| 2024-12-31 | CN¥4.85 Billion ≈ $709.51 Million |
+10.49% |
| 2023-12-31 | CN¥4.39 Billion ≈ $642.15 Million |
+10.49% |
| 2022-12-31 | CN¥3.97 Billion ≈ $581.17 Million |
+53.14% |
| 2021-12-31 | CN¥2.59 Billion ≈ $379.49 Million |
+40.15% |
| 2020-12-31 | CN¥1.85 Billion ≈ $270.78 Million |
+98.71% |
| 2019-12-31 | CN¥931.21 Million ≈ $136.27 Million |
+42.19% |
| 2018-12-31 | CN¥654.91 Million ≈ $95.83 Million |
+44.72% |
| 2017-12-31 | CN¥452.54 Million ≈ $66.22 Million |
+26.79% |
| 2016-12-31 | CN¥356.93 Million ≈ $52.23 Million |
+45.55% |
| 2015-12-31 | CN¥245.24 Million ≈ $35.89 Million |
+39.41% |
| 2014-12-31 | CN¥175.91 Million ≈ $25.74 Million |
+7.25% |
| 2013-12-31 | CN¥164.02 Million ≈ $24.00 Million |
-- |
About Shanghai Titan Scientific Co. Ltd. A
Shanghai Titan Scientific Co., Ltd. engages in the provision of laboratory products and supporting services for scientific researchers and quality control personnel. The company offers scientific research reagents, special chemicals, scientific research instruments and consumables, laboratory construction, and scientific research information services. It serves universities, hospitals, research i… Read more